Locations:
Search
Data point to potential for targeted preconception planning
Robust signal from observational study raises prospect of a long-sought medical therapy
Post hoc analysis of SURPASS-CVOT trial has implications for future cardiovascular outcome trials
Retrospective analysis finds lower mortality rates, fewer hospital visits among patients with Type 1 diabetes using GLP-1 Therapies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Data could help inform policy and patient-provider conversations
Study shows significantly reduced risk of mortality and disease complications in patients receiving GLP-1 agonists
A reconcilable divorce
Observational evidence of neuroprotection with GLP-1 receptor agonists and SGLT-2 inhibitors
Study is first to show reduction in autoimmune disease with the common diabetes and obesity drugs
Surgical intervention linked to increased lifespan and reduced complications
Advertisement
Advertisement